#TomorrowsDiscoveries: Chemotherapy-Resistant Breast Cancer Stem Cells | Dr. Gregg Semenza

#TomorrowsDiscoveries: While chemotherapy attacks and kills 99 percent of breast cancer cells, it leaves behind chemotherapy-resistant cancer stem cells, which can later cause metastatic tumors. Dr. Gregg Semenza’s team has identified a way to overcome the resistance of cancer stem cells to chemotherapy, completely eradicating breast tumors in mice. Learn more about Dr. Semenza’s work:

Created by

Johns Hopkins Medicine

Related Presenters

Gregg Semenza
, MD, PhD

Gregg Semenza, MD, PhD

Director, Vascular Program, Institute for Cell Engineering

Dr. Gregg L. Semenza is a professor of pediatrics, radiation oncology and molecular radiation sciences, biological chemistry, medicine, and oncology at the Johns Hopkins University School of Medicine. Dr. Semenza is the C. Michael Armstrong ...

View full profile